Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.4906
+0.0016 (0.33%)
At close: Jun 24, 2026, 4:00 PM EDT
0.4902
-0.0004 (-0.08%)
After-hours: Jun 24, 2026, 7:25 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $13.74 million as of June 24, 2026. Its market cap has decreased by -84.61% in one year.
Market Cap
13.74M
Enterprise Value
348.24K
1-Year Change
-84.61%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $13.74M, a decrease of -88.81%. That is a compound annual growth rate of -28.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 13.74M | -73.18% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.23M |
| Quince Therapeutics | 15.12M |
| BioVie | 14.63M |
| Lexaria Bioscience | 14.45M |
| IN8bio | 14.38M |
| BioLineRx | 14.10M |
| Cocrystal Pharma | 13.79M |
| Cyclerion Therapeutics | 13.66M |